Mankind Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 2,667.49 | 2,527.33 | 2,103.98 |
| Operating Expense | 1,777.71 | 1,831.06 | 1,481.38 |
| Net Profit | 634.43 | 513.49 | 454.17 |
| Net Profit Margin | 23.78 | 20.32 | 21.59 |
| Earning Per Share | 15.84 | 12.82 | 11.34 |
| EBIDTA | 853.00 | 711.49 | 644.98 |
| Effective Tax Rate | 14.75 | 15.56 | 16.79 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 2667.49 |
| Operating Expense | 1777.71 |
| Net Profit | 634.43 |
| Net Profit Margin | 23.78 |
| Earning Per Share | 15.84 |
| EBIDTA | 853.00 |
| Effective Tax Rate | 14.75 |
Invest in Mankind Pharma Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 9,264.81 | 8,127.15 | 7,486.22 |
| Operating Expenses Annual | 6,939.70 | 6,429.77 | 5,648.15 |
| Operating Profit Annual | 2,591.74 | 1,860.16 | 2,041.89 |
| Interest Annual | 14.57 | 27.75 | 47.12 |
| Depreciation | 155.62 | 111.13 | 98.35 |
| Net Profit Annual | 1,823.41 | 1,248.26 | 1,389.42 |
| Tax Annual | 436.16 | 314.58 | 482.01 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 9,264.81 |
| Operating Expenses Annual | 6,939.70 |
| Operating Profit Annual | 2,591.74 |
| Interest Annual | 14.57 |
| Depreciation | 155.62 |
| Net Profit Annual | 1,823.41 |
| Tax Annual | 436.16 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 134.13 | 86.17 | 46.36 |
| Cash Flow from Operations | 1,982.97 | 1,798.99 | 821.44 |
| Cash Flow from Investing | -1,919.22 | -1,040.61 | -1,360.27 |
| Cash Flow from Financing | -8.68 | -710.41 | 578.63 |
| Cash Flow at the End | 189.20 | 134.13 | 86.17 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 134.13 |
| Cash Flow from Operations | 1,982.97 |
| Cash Flow from Investing | -1,919.22 |
| Cash Flow from Financing | -8.68 |
| Cash Flow at the End | 189.20 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 27.98 | 22.89 | 27.28 |
| PBIT Margin (%) | 24.55 | 19.58 | 25.63 |
| PBT Margin (%) | 22.92 | 18.89 | 25.09 |
| Net PROFIT Margin (%) | 19.68 | 15.36 | 18.56 |
| Return On Networth / Equity (%) | 20.95 | 17.43 | 24.65 |
| Return On Networth /Employed (%) | 25.77 | 20.91 | 31.42 |
| Return On Assets (%) | 20.67 | 16.43 | 22.83 |
| Total Debt / Equity (X) | TBA | 0.05 | 0.07 |
| Asset Turnover Ratio (%) | 1.05 | 1.07 | 1.23 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 27.98 |
| PBIT Margin (%) | 24.55 |
| PBT Margin (%) | 22.92 |
| Net PROFIT Margin (%) | 19.68 |
| Return On Networth / Equity (%) | 20.95 |
| Return On Networth /Employed (%) | 25.77 |
| Return On Assets (%) | 20.67 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 1.05 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 3,473.77 | 3,193.85 | 2,952.58 |
| Total Current Assets Annual | 5,490.41 | 3,516.91 | 3,815.71 |
| Non Current Assets Annual | 5,927.30 | 5,854.21 | 5,122.99 |
| Total Shareholders Funds Annual | 9,623.81 | 7,783.91 | 6,540.45 |
| Total Assets Annual | 11,417.71 | 9,371.12 | 8,938.70 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 3,473.77 |
| Total Current Assets Annual | 5,490.41 |
| Non Current Assets Annual | 5,927.30 |
| Total Shareholders Funds Annual | 9,623.81 |
| Total Assets Annual | 11,417.71 |
EPS (INR)
Expected
16.31
Reported
16.31
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
